Advanced search
Publication Cover
Journal of Medical Economics Volume 15, 2012 - Issue 2
Submit an article Journal homepage
774
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico

Fernando CarlosR A C Salud Consultores, S.A. de C.V. Ciudad de MéxicoMéxicoCorrespondence[email protected] [email protected]
,
Jocelyn Ramírez-GámezEli Lilly y Compañía de México, S.A. de C.V. Ciudad de MéxicoMéxico
,
Héctor DueñasEli Lilly y Compañía de México, S.A. de C.V. Ciudad de MéxicoMéxico
,
Rosa María Galindo-SuárezEli Lilly y Compañía de México, S.A. de C.V. Ciudad de MéxicoMéxico
&
Elisa RamosR A C Salud Consultores, S.A. de C.V. Ciudad de MéxicoMéxico
Pages 233-244 | Accepted 09 Nov 2011, Published online: 05 Dec 2011

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jiejin Zhu, Wanshu Li, Changcheng Shi & Qingyu Li. (2022) A pharmacoeconomic evaluation of the pharmacotherapeutic options for painful diabetic neuropathy. Expert Opinion on Pharmacotherapy 23:5, pages 551-559.
Read now
Simone Critchlow, Matthew Hirst, Ron Akehurst, Ceri Phillips, Zoe Philips, Will Sullivan & Will C.N. Dunlop. (2017) A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future. Journal of Medical Economics 20:2, pages 129-139.
Read now
Jordan B King, Marisa B Schauerhamer & Brandon K Bellows. (2015) A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 1163-1175.
Read now

Articles from other publishers (7)

Natalia Ruiz-Negrón, Jyothi Menon, Jordan B. King, Junjie Ma & Brandon K. Bellows. (2019) Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review. PharmacoEconomics 37:5, pages 669-688.
Crossref
Masoud Mohammadi, Ali Akbar Vaisi Raiegani, Rostam Jalali, Akram Ghobadi & Nader Salari. (2019) The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders 20:1, pages 79-88.
Crossref
Kenneth D. Candido, Joseph Chiweshe, Utchariya Anantamongkol & Nebojsa Nick Knezevic. (2016) Can Chronic Pain Patients Be Adequately Treated Using Generic Pain Medications to the Exclusion of Brand-Name Ones?. American Journal of Therapeutics 23:2, pages e489-e497.
Crossref
Brandon K. Bellows, Richard E. Nelson, Gary M. Oderda & Joanne LaFleur. (2016) Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine. Pain 157:1, pages 203-213.
Crossref
Fernando Carlos, Luis Espejel, Diego Novick, Rubén López & Daniel Flores. (2015) Duloxetina para el tratamiento de la neuropatía diabética periférica dolorosa en Venezuela: evaluación económica. Medwave 15:08, pages e6265-e6265.
Crossref
Lindsay Parker, Rachel Huelin, Zarmina Khankhel, Radek Wasiak & Joaquin Mould. (2015) A Systematic Review of Pharmacoeconomic Studies for Pregabalin. Pain Practice 15:1, pages 82-94.
Crossref
Miguel Elizondo-Cano, Fernando Carlos-Rivera, Jocelyn Ramírez-Gámez & Héctor Dueñas. (2014) Evaluación económica del uso de duloxetina en el tratamiento del dolor crónico causado por osteoartritis de rodilla en el sistema privado de salud en México. PharmacoEconomics Spanish Research Articles 11:3, pages 61-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.